Danielle Meyrick

Danielle Meyrick

Company: ITM

Job title: Chief Medical Officer


Session Reserved for Advancing the Future of Radiopharmaceutical Therapy 9:45 am

Advancing the Future of Radiopharmaceutical Therapy   Understanding the clinical needs for alpha, beta and auger emitting isotopes for RPT Exploring the past to guide future clinical trials and radiopharmaceutical developmentRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.